Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » Sequencing » Single-Cell Study Details Development of Chemoresistant Breast Cancer

Single-Cell Study Details Development of Chemoresistant Breast Cancer

Apr 19, 2018
|
staff reporter

NEW YORK (GenomeWeb) - A pilot study using single-cell sequencing to analyze the evolution of chemotherapy-resistant triple-negative breast cancer suggests that resistance arises from pre-existing clones with genetic mutations. However, transcriptional profiles associated with the cancer subtype can develop via reprogramming in response to chemotherapy.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Dec
15
Featured Webinar

Case Study: Deployment of High-Throughput SARS-CoV-2 Testing at UC Davis

Sponsored by
UgenTec

Diverse components of the UC Davis campus have been mobilized to deploy HTP testing to provide a safe working environment and keep the pandemic under control.

What's Popular?

In Cancer

  1. Ravgen Sues Illumina, Roche Alleging Infringement of Cell-Free DNA Testing Patents

  2. Illumina, New York Healthcare Providers, NYGC Partner on Clinical Whole-Genome Sequencing

  3. Breast Cancer Trial Data Supports Neoadjuvant Use of Natera Liquid Biopsy

    Premium

  4. MMRF, Dana Farber Partner on Search for Biomarkers Linked to Smoldering Multiple Myeloma Progression

  5. Grail Inks Deal With UK National Health Service to Offer Cancer Screening Blood Test in 2021

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.